Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

RBC hails "underappreciated" growth potential at Serco

(Sharecast News) - RBC Capital Markets has reiterated its 'outperform' call on Serco Group, saying the essential public services providers' strong execution and prospects are currently "underappreciated" by the market. In an in-depth research report published on Tuesday, RBC highlighted Serco's "robust drivers" across and diverse business mix, where addressable markets remain large with "significant room for growth".

"Top down drivers remain strong given high public debt levels, political change, geopolitics, increased focus on matters beyond price and capability in bids and the increased use of technology. Key markets like Defence, Immigration and Health all have current structural growth drivers," the broker said.

Meanwhile, the company's business in the North American defence market has been a "major success story" over the past five years, but is overlooked by the market, it added.

"The shares have been lacklustre, despite strong financial delivery, and we believe SRP is now materially undervalued. [...] In an uncertain world and an expensive overall Business Services sector, we believe Serco warrants attention," RBC said.

The broker kept a 230p target price for the stock, which was trading 1% higher at 173.60p on Tuesday morning.

Share this article

Related Sharecast Articles

Berenberg lowers target price on Impax Asset Management
(Sharecast News) - Analysts at Berenberg lowered their target price on Impax Asset Management from 620.0p to 560.0p on Tuesday but noted that outflows had started to slow.
GSK's Arexvy provides protection over three RSV seasons, trial shows
(Sharecast News) - GSK has announced positive results from a phase III trial of its Arexvy RSV vaccine, showing that just one dose of the treatment could help protect older adults at risk of RSV disease over three seasons.
S&U revenue up, profitability a challenge in first half
(Sharecast News) - Motor and property finance specialist S&U reported a mixed first-half financial performance on Tuesday, after group revenue increased 9% year-on-year to £60.4m.
Loungers reports slight slowdown in LFL sales growth
(Sharecast News) - Cosy Club owner Loungers reported a slight slowdown in like-for-like sales growth on Tuesday and a jump in revenue.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.